Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
Pascale Salameh,
Kamal Matli,
Nibal Chamoun,
Georges Ghanem,
Aya Fares,
Victor Zibara,
Soad Al-Osta,
Rabih Nasrallah,
Jacques Mokhbat
Affiliations
Pascale Salameh
2 Pharmacy, Lebanese University, Beirut, Lebanon
Kamal Matli
Lebanese American University Medical Center, Rizk Hospital, Beirut, Lebanon
Nibal Chamoun
School of Pharmacy, Lebanese American University, Byblos, Lebanon
Georges Ghanem
Lebanese American University Medical Center, Rizk Hospital, Beirut, Lebanon
Aya Fares
Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon
Victor Zibara
Lebanese American University School of Medicine, Byblos, Lebanon
Soad Al-Osta
Lebanese American University School of Medicine, Byblos, Lebanon
Rabih Nasrallah
Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon
Jacques Mokhbat
Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon